跳至主要内容
临床试验/NCT07307651
NCT07307651尚未招募不适用

Implementation of an RT-PCR Assay for the Diagnosis of Rickettsia Spp. Infection

IRCCS Azienda Ospedaliero-Universitaria di Bologna2 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2026年1月7日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
800
试验地点
2
主要终点
To evaluate the early diagnostic capability of molecular testing (RT-PCR) for the diagnosis of Rickettsia infection at the time of first blood sampling in suspected cases.

研究概览

简要总结

Rickettsia2024 is a multicenter, tissue observational, retrospective and prospective cohort study. Enrollment will take place within the outpatient clinics of the Infectious Diseases and Dermatology Unit of the IRCCS AOUBO and, following an infectious disease consultation in the Bologna Metropolitan area, at the Hospitals and CAUs of the Bologna Local Health Authority. Within these UUOOs, biopsy samples from normal clinical practice are performed on patients with strong clinical suspicion of Rickettsia infection: therefore, it will not be necessary to perform any additional samples for the conduct of this study. Samples from the normal diagnostic process are sent to the Microbiology UOC, where they are subjected to various analyses. RT-PCR analyses (commercial or in-house kit) and assay of species-specific IgG antibodies will be performed according to clinical practice. Additional tests will be performed with a commercial kit for retrospective samples and with a home-made method for prospective samples.

详细描述

It is estimated that a total of approximately 800 patients can be recruited, 400 for the retrospective part and the same number for the prospective part (estimated using data collected from requests received to date). For the retrospective cohort: from January 2023 until approval by the ethics committee; For the prospective cohort: from ethics committee approval until December 2027.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • pazienti che presentano escara
  • pazienti con richiesta del dosaggio degli anticorpi anti-Rickettsia conorii

排除标准

  • 未提供

结局指标

主要结局

To evaluate the early diagnostic capability of molecular testing (RT-PCR) for the diagnosis of Rickettsia infection at the time of first blood sampling in suspected cases.

时间窗: from January 7, 2026 to June 7, 2028

次要结局

  • Estimation of the incidence of Rickettsia conorii infections in the Bologna metropolitan area through serological screening(from January 7, 2026 to June 7, 2028)
  • Comparison of the sensitivity and specificity of diagnosis of in-house RT-PCR and commercial kit (Rickettsia spp REAL TIME PCR, Immunospark)(from January 7, 2026 to June 7, 2028)
  • Identification of Rickettsia species by gene sequencing of the 16S rRNA portion of samples tested positive (threshold cycle < 30) by in-house RT-PCR/commercial kit(from January 7, 2026 to June 7, 2028)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验